UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 133

Sortiert nach

Cabozantinib in Japanese patients with advanced hepatocellular carcinoma: a phase 2 multicenter study

Journal of gastroenterology, 2021-02, Vol.56 (2), p.181-190

2021

Volltextzugriff (PDF)

Serum alpha-fetoprotein and clinical outcomes in patients with advanced hepatocellular carcinoma treated with ramucirumab

British journal of cancer, 2021-04, Vol.124 (8), p.1388-1397

2021

Volltextzugriff (PDF)

Ramucirumab after prior sorafenib in patients with advanced hepatocellular carcinoma and elevated alpha-fetoprotein: Japanese subgroup analysis of the REACH-2 trial

Journal of gastroenterology, 2020-06, Vol.55 (6), p.627-639

2020

Volltextzugriff (PDF)

A randomized, double‐blind, placebo‐controlled, phase 3 study of tivantinib in Japanese patients with MET‐high hepatocellular carcinoma

Cancer science, 2020-10, Vol.111 (10), p.3759-3769

2020

Volltextzugriff (PDF)

Potential Predictive Biomarkers of Systemic Drug Therapy for Hepatocellular Carcinoma: Anticipated Usefulness in Clinical Practice

Cancers, 2023-08, Vol.15 (17), p.4345

2023

Volltextzugriff (PDF)

Esophageal Perforation Associated With a Single Dose of Bisphosphonate

Gastro hep advances, 2023, Vol.2 (5), p.621-622

2023

Volltextzugriff (PDF)

Avelumab in Combination with Axitinib as First-Line Treatment in Patients with Advanced Hepatocellular Carcinoma: Results from the Phase 1b VEGF Liver 100 Trial

Liver cancer (Basel ), 2021-06, Vol.10 (3), p.249-259

2021

Volltextzugriff (PDF)

Cabozantinib in Japanese patients with advanced hepatocellular carcinoma: Final results of a multicenter phase II study

Hepatology research, 2023-05, Vol.53 (5), p.409-416

2023

Volltextzugriff (PDF)

Prognostic factors associated with mortality in patients with gastric fundal variceal bleeding

World journal of gastroenterology : WJG, 2017-01, Vol.23 (3), p.496-504

2017

Volltextzugriff (PDF)

Indicators of sorafenib efficacy in patients with advanced hepatocellular carcinoma

World journal of gastroenterology : WJG, 2014-09, Vol.20 (35), p.12581-12587

2014

Volltextzugriff (PDF)

A case of multiple osteonecrosis caused by acute-on-chronic pancreatitis

Nippon Shokakibyo Gakkai Zasshi, 2022/08/10, Vol.119(8), pp.761-767

2022

Volltextzugriff (PDF)

Risk factors for loss to follow‐up after the start of direct‐acting antiviral treatment for hepatitis C virus infection

JGH open, 2023-02, Vol.7 (2), p.98-104

2023

Volltextzugriff (PDF)

Safety and Effectiveness of Lenvatinib in Patients with Unresectable Hepatocellular Carcinoma in Real-World Clinical Practice: An Observational Post-Marketing Study in Japan

Drugs -- real world outcomes, 2023-06, Vol.10 (2), p.195-205

2023

Volltextzugriff (PDF)

Efficacy of tolvaptan for the patients with advanced hepatocellular carcinoma

World journal of gastroenterology : WJG, 2017-08, Vol.23 (29), p.5379-5385

2017

Volltextzugriff (PDF)

A case of elderly-onset erythropoietic protoporphyria diagnosed at autopsy

Kanzo, 2023/05/01, Vol.64(5), pp.235-242

2023

Volltextzugriff (PDF)

A case of granulocyte colony-stimulating factor-producing intrahepatic sarcomatoid cholangiocarcinoma

Clinical journal of gastroenterology, 2021-06, Vol.14 (3), p.881-887

2021

Volltextzugriff (PDF)

Peroxisome Proliferator-activated Receptors and Hepatic Stellate Cell Activation

The Journal of biological chemistry, 2000-11, Vol.275 (46), p.35715-35722

2000

Volltextzugriff (PDF)

Word decoding of protein amino Acid sequences with availability analysis: a linguistic approach

PloS one, 2012-11, Vol.7 (11), p.e50039-e50039

2012

Volltextzugriff (PDF)

慢性膵炎急性増悪に続発し，保存的治療で軽快した多発性骨壊死の1例

日本消化器病学会雑誌, 2022/08/10, Vol.119(8), pp.761-767

2022

Volltextzugriff (PDF)

ペムブロリズマブによる硬化性胆管炎に対しステロイドパルス療法が著効した1例

日本消化器病学会雑誌, 2021/10/10, Vol.118(10), pp.981-990

2021

Volltextzugriff (PDF)

A frequency-based linguistic approach to protein decoding and design: Simple concepts, diverse applications, and the SCS Package

Computational and structural biotechnology journal, 2013-02, Vol.5 (6), p.e201302010-e201302010, Article e201302010

2013

Volltextzugriff (PDF)

Immediate virological response predicts the success of shortterm peg-interferon monotherapy for chronic hepatitis C

World journal of gastroenterology : WJG, 2010, Vol.16 (12), p.1506-1511

Masayoshi Yada Akihide Masumoto Naoki Yamashita Kenta Motomura Toshimasa Koyanagi Shigeru Sakamoto

2010

Volltextzugriff (PDF)

Serum α‐fetoprotein level at treatment completion is a useful predictor of hepatocellular carcinoma occurrence more than one year after hepatitis C virus eradication by direct‐acting antiviral treatment

Journal of viral hepatitis, 2022-01, Vol.29 (1), p.35-42

2022

Volltextzugriff (PDF)

1 – 25 von 133

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(85)
Mit Volltextzugriff
(129)

Publikationsform

Sprache

Englisch
(90)
Japanisch
(51)

Erscheinungsjahr

n.n

Thema

Science & Technology
(51)
Life Sciences & Biomedicine
(48)
Hepatocellular Carcinoma
(29)
Humans
(23)
Gastroenterology & Hepatology
(22)
Male
(22)
Liver Cancer
(17)
Middle Aged
(14)
Patients
(14)
Biological And Medical Sciences
(12)
Female
(12)
Aged
(11)
Medical Sciences
(10)
Animals
(9)
Carcinoma, Hepatocellular - Drug Therapy
(9)
Liver Neoplasms - Drug Therapy
(9)
Oncology
(9)
Hepatoma
(8)
Medical Prognosis
(8)
Treatment Outcome
(8)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Cabozantinib in Japanese patients with advanced hepatocellular carcinoma: a phase 2 multicenter study

Serum alpha-fetoprotein and clinical outcomes in patients with advanced hepatocellular carcinoma treated with ramucirumab

Ramucirumab after prior sorafenib in patients with advanced hepatocellular carcinoma and elevated alpha-fetoprotein: Japanese subgroup analysis of the REACH-2 trial

A randomized, double‐blind, placebo‐controlled, phase 3 study of tivantinib in Japanese patients with MET‐high hepatocellular carcinoma

Potential Predictive Biomarkers of Systemic Drug Therapy for Hepatocellular Carcinoma: Anticipated Usefulness in Clinical Practice

Esophageal Perforation Associated With a Single Dose of Bisphosphonate

Factors Contributing to the Prognosis after Second-line Therapy with Ramucirumab in Advanced Hepatocellular Carcinoma

Avelumab in Combination with Axitinib as First-Line Treatment in Patients with Advanced Hepatocellular Carcinoma: Results from the Phase 1b VEGF Liver 100 Trial

Cabozantinib in Japanese patients with advanced hepatocellular carcinoma: Final results of a multicenter phase II study

Prognostic factors associated with mortality in patients with gastric fundal variceal bleeding

Indicators of sorafenib efficacy in patients with advanced hepatocellular carcinoma

A case of multiple osteonecrosis caused by acute-on-chronic pancreatitis

Risk factors for loss to follow‐up after the start of direct‐acting antiviral treatment for hepatitis C virus infection

Safety and Effectiveness of Lenvatinib in Patients with Unresectable Hepatocellular Carcinoma in Real-World Clinical Practice: An Observational Post-Marketing Study in Japan

Efficacy of tolvaptan for the patients with advanced hepatocellular carcinoma

A case of elderly-onset erythropoietic protoporphyria diagnosed at autopsy

A case of granulocyte colony-stimulating factor-producing intrahepatic sarcomatoid cholangiocarcinoma

Peroxisome Proliferator-activated Receptors and Hepatic Stellate Cell Activation

Word decoding of protein amino Acid sequences with availability analysis: a linguistic approach

慢性膵炎急性増悪に続発し，保存的治療で軽快した多発性骨壊死の1例

ペムブロリズマブによる硬化性胆管炎に対しステロイドパルス療法が著効した1例

A frequency-based linguistic approach to protein decoding and design: Simple concepts, diverse applications, and the SCS Package

Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial

Immediate virological response predicts the success of shortterm peg-interferon monotherapy for chronic hepatitis C

Serum α‐fetoprotein level at treatment completion is a useful predictor of hepatocellular carcinoma occurrence more than one year after hepatitis C virus eradication by direct‐acting antiviral treatment

Suchergebnisse filtern